The COVID-19 pandemic led to many changes. Among them is universal familiarity with a molecular diagnostic technique that was largely unknown outside clinical use. The polymerase chain reaction — or ...

“Infectious diseases don’t respect borders,” says Khoa Thai, a clinical microbiologist at the Star-shl medical diagnostics laboratory in the Netherlands. To limit their spread, we need a globally ...

Last week, I was about to go on a date, and because I'm severely immunocompromised, we agreed he would take a COVID test ...

PCR-based bacterial and fungal detection helps scientists efficiently analyze the sterility of their cell cultures, improving Mycoplasma testing and beyond. Scientists turn to PCR-based methods that ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

Robust sterility testing is essential to ensure the safety of cell therapies. However, traditional culture-based analysis takes several weeks to confirm a therapeutic’s microbial contamination, which ...

Because no additional PCR tests are conducted, the extent of false negatives in rapid antigen tests remains ... Im Sook-young, head of the Central Disease Control Headquarters' situation management ...